Evoke Pharma Inc Annual Operating Income (Loss) in USD from 2011 to 2023

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
Evoke Pharma Inc quarterly/annual Operating Income (Loss) history and growth rate from 2011 to 2023.
  • Evoke Pharma Inc Operating Income (Loss) for the quarter ending June 30, 2024 was -$1.22M, a 31.4% increase year-over-year.
  • Evoke Pharma Inc Operating Income (Loss) for the twelve months ending June 30, 2024 was -$6.22M, a 17.8% increase year-over-year.
  • Evoke Pharma Inc annual Operating Income (Loss) for 2023 was -$7.43M, a 4.56% increase from 2022.
  • Evoke Pharma Inc annual Operating Income (Loss) for 2022 was -$7.79M, a 4.48% increase from 2021.
  • Evoke Pharma Inc annual Operating Income (Loss) for 2021 was -$8.15M, a 37.5% increase from 2020.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Annual (USD)
Operating Income (Loss), YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 -$7.43M +$355K +4.56% Jan 1, 2023 Dec 31, 2023 10-K/A 2024-05-14
2022 -$7.79M +$366K +4.48% Jan 1, 2022 Dec 31, 2022 10-K/A 2024-05-14
2021 -$8.15M +$4.9M +37.5% Jan 1, 2021 Dec 31, 2021 10-K 2023-03-21
2020 -$13M -$5.89M -82.4% Jan 1, 2020 Dec 31, 2020 10-K 2022-03-08
2019 -$7.15M +$860K +10.7% Jan 1, 2019 Dec 31, 2019 10-K 2021-03-11
2018 -$8.01M +$3.22M +28.6% Jan 1, 2018 Dec 31, 2018 10-K 2020-03-12
2017 -$11.2M -$686K -6.51% Jan 1, 2017 Dec 31, 2017 10-K 2019-03-06
2016 -$10.5M +$1.27M +10.8% Jan 1, 2016 Dec 31, 2016 10-K 2018-03-07
2015 -$11.8M +$1.33M +10.1% Jan 1, 2015 Dec 31, 2015 10-K 2017-03-15
2014 -$13.2M -$10.5M -405% Jan 1, 2014 Dec 31, 2014 10-K 2016-03-10
2013 -$2.6M -$599K -29.9% Jan 1, 2013 Dec 31, 2013 10-K 2015-03-04
2012 -$2M +$412K +17.1% Jan 1, 2012 Dec 31, 2012 10-K 2014-03-25
2011 -$2.41M Jan 1, 2011 Dec 31, 2011 10-K 2014-03-25
* An asterisk sign (*) next to the value indicates that the value is likely invalid.